Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Citron's Andrew Left digs in heels on GSX short after 200% rally

Published 08/13/2020, 02:28 PM
Updated 08/13/2020, 02:30 PM
© Reuters.

By Saqib Iqbal Ahmed

NEW YORK (Reuters) - Short-seller Andrew Left is betting the Trump Administration's hardening line on U.S.-listed Chinese companies will help derail a rally in the shares of GSX Techedu Inc (N:GSX), which have surged some 200% since his firm announced its short position in the stock.

The Beijing-based online education company has been attacked by short sellers, including Andrew Left's Citron Capital, which has accused it of overstating revenue by up to 70%.

That's done little to stem the rise in the company's shares, part of a global stock surge that has trampled bearish bets across markets.

"Yes, it obviously sucks being short while the stock was going higher," Left said on Wednesday. "But I have confidence the system will work eventually."

Left, editor of the online investment newsletter Citron Research, published a short report on GSX in mid April.

GSX, which has called Citron's allegations false and ungrounded, said it had no further comment.

Fresh hope for Left came earlier this week, when U.S. Treasury Secretary Steven Mnuchin on Monday said companies from China and other countries that do not comply with accounting standards will be delisted from U.S. stock exchanges as of the end of 2021.

"It gives me more confidence. It makes me think that Deloitte will take a second look at this," Left said.

GSX's auditor Deloitte Touche Tohmatsu did not respond to a request for comment.

The relentless rally in stocks has pressured some bearish investors betting against individual stocks as well as broader markets.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Influential U.S. investors, including David Tepper and Stanley Druckenmiller, cast doubt on the rally earlier in the year. Druckenmiller in June said he had become more bullish on stocks.

Citron Capital returned 43% after fees in 2019, its first year in business.

Left did not provide numbers for the fund's 2020 performance.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.